Therapeutic Peptides Expanded 2 intermediate
Bepranemab: Oligopeptide Research Reference
Bepranemab, a bioactive peptide compound with documented applications in biomedical research, pharmacological studies, and therapeutic development
By Encyclopeptide Editorial | 1 min read
therapeutic-peptides-expanded-2 peptide oligopeptide
Overview
Bepranemab is a bioactive peptide with well-characterized properties and therapeutic applications.
Structure
| Property | Value |
|---|---|
| Name | Bepranemab |
| Sequence | Humanized monoclonal antibody targeting tau protein mid-region (aa 235–250) |
| Length | ~1330 amino acids |
| Molecular Weight | ~148 kDa |
| Category | Neurology / Anti-Tau Antibody |
Mechanism of Action
Targets the mid-region of tau (residues 235–250), blocking tau seeding and cell-to-cell propagation of pathological tau species
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Test Your Knowledge
Reinforce what you learned about Bepranemab: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept